Search research articles
Contact Us
Filters
Showing results (11-20 of 57) with videos related to
Page
of 6
Sort By:
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine
|
January 16, 2019
[Mechanisms of Fufang Shixiao Formula for Experimental Primary Dysmenorrhea]
Qian Ll, Ping Xie, Chun-Xia Bai, et al.
Journal of Hematology & Oncology
|
November 15, 2017
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
Yi-Hua Lai, Sih-Yin Lin, Yu-Shan Wu, et al.
Chemico-Biological Interactions
|
March 15, 2022
3,5,2',4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway
Yi-Chun Chiang, Yu-Shan Wu, Ya-Fei Kang, et al.
Journal of Natural Products
|
September 8, 2021
Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs
Chung-Pu Wu, Yan-Qing Li, Tai-Ho Hung, et al.
International Journal of Molecular Sciences
|
September 10, 2021
The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung-Pu Wu, Yan-Qing Li, Ya-Chen Chi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 21, 2025
The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs
Yen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.
The Journal of Pharmacy and Pharmacology
|
March 16, 2026
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB1
Yen-Ching Li, Megumi Murakami, Yang-Hui Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 23, 2019
Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases
Shu-Li Yang, Ying-Hao Wen, Yu-Shan Wu, et al.
Cancer Letters
|
July 22, 2018
The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines
Sung-Han Hsiao, Megumi Murakami, Ni Yeh, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2012
Discovery of potent antimicrobial peptide analogs of Ixosin-B
Feng-Di T Lung, Kai-Shiuan Wang, Zih-Jie Liao, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 57) with videos related to
Sort By:
Page
of 6
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine
|
January 16, 2019
[Mechanisms of Fufang Shixiao Formula for Experimental Primary Dysmenorrhea]
Qian Ll, Ping Xie, Chun-Xia Bai, et al.
Journal of Hematology & Oncology
|
November 15, 2017
AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways
Yi-Hua Lai, Sih-Yin Lin, Yu-Shan Wu, et al.
Chemico-Biological Interactions
|
March 15, 2022
3,5,2',4'-Tetramethoxystilbene, a fully methylated resveratrol analog, prevents platelet aggregation and thrombus formation by targeting the protease-activated receptor 4 pathway
Yi-Chun Chiang, Yu-Shan Wu, Ya-Fei Kang, et al.
Journal of Natural Products
|
September 8, 2021
Sophoraflavanone G Resensitizes ABCG2-Overexpressing Multidrug-Resistant Non-Small-Cell Lung Cancer Cells to Chemotherapeutic Drugs
Chung-Pu Wu, Yan-Qing Li, Tai-Ho Hung, et al.
International Journal of Molecular Sciences
|
September 10, 2021
The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
Chung-Pu Wu, Yan-Qing Li, Ya-Chen Chi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 21, 2025
The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs
Yen-Ching Li, Bing-Huan Lin, Megumi Murakami, et al.
The Journal of Pharmacy and Pharmacology
|
March 16, 2026
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB1
Yen-Ching Li, Megumi Murakami, Yang-Hui Huang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 23, 2019
Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases
Shu-Li Yang, Ying-Hao Wen, Yu-Shan Wu, et al.
Cancer Letters
|
July 22, 2018
The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines
Sung-Han Hsiao, Megumi Murakami, Ni Yeh, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2012
Discovery of potent antimicrobial peptide analogs of Ixosin-B
Feng-Di T Lung, Kai-Shiuan Wang, Zih-Jie Liao, et al.
Page
of 6